|

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RECRUITINGPhase 3Sponsored by Eli Lilly and Company
Actively Recruiting
PhasePhase 3
SponsorEli Lilly and Company
Started2026-08-26
Est. completion2029-08
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations80 sites

Summary

This study will evaluate the efficacy and safety of orforglipron in participants with overweight and assess whether it helps reduce the future risk of obesity-related conditions, including type 2 diabetes, hypertension, and dyslipidemia, and progression to class 1 obesity.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Have an increased waist-to-height ratio of ≥0.5
* Have at least one pre-obesity-related complication (prediabetes, prehypertension, predyslipidemia)
* Have at least one unsuccessful attempt to reduce body weight based on diet and exercise
* Have a BMI greater than or equal to 25 to less than or equal to 29.9 kg/m2 or equivalent-/region-specific overweight thresholds

Exclusion Criteria:

* Have type 1 diabetes, type 2 diabetes, or any other type of diabetes
* Do not have a stable body weight within 90 days before screening
* Have a documented obesity diagnosis or self-reported history of BMI ≥30 kg/m² (or an equivalent region-specific threshold)
* Have taken medications for weight loss, including over-the counter medications or alternative therapies, within 180 days prior to screening
* Have a prior or planned surgical treatment or procedure for obesity
* Have hypertension or history of hypertension
* Have dyslipidemia or history of dyslipidemia

Conditions5

DiabetesObesity, AbdominalOverweightPrediabetic StatePrehypertension

Interventions1

Locations80 sites

Pinnacle Research Group, LLC
Anniston, Alabama, 36207
256-236-0055
Central Research Associates
Birmingham, Alabama, 35205
205-327-1077
Cahaba Research - Pelham
Pelham, Alabama, 35124
205-408-4134
Care Access - 801 South Power Road, Mesa
Mesa, Arizona, 85206
877-791-0656
Absolute Clinical Research
James Beach

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.